Chen Wang

Dr. Chen Wang is an Associate Research Fellow at Shanghai Tongren Hospital, specializing in the discovery and validation of novel therapeutic targets, drug sensitization, and resistance mechanisms in gastrointestinal cancers. She received her PhD from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, in 2019 and subsequently completed postdoctoral training at City of Hope, The Wistar Institute, and The University of Texas MD Anderson Cancer Center. Her research integrates functional genomics, epigenetics, and cancer therapeutics, with expertise in CRISPR screening, base editing, next-generation sequencing technologies, and bioinformatics analysis. Dr. Wang has published over 30 peer-reviewed articles, including first-author papers in Nature Communications, Theranostics, and Journal of Medicinal Chemistry.